A massive market divergence is unfolding as the China-plus-one strategy triggers a chemical profit surge, even as looming US drug tariffs threaten the Indian pharma sector. Analysis includes #AcutaasChemicals, #BandhanBank, #SunflagIron, #GoodluckIndia, #HPCL, and #Lupin. Subscribe to stay ahead of the market moves and policy shifts defining the world's fastest-growing major economy.